|
1
|
Hundae A and McCullough PA: Cardiac and
renal fibrosis in chronic cardiorenal syndromes. Nephron Clin
Pract. 127:106–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen YX, Zhang W, Wang WM, Yu XL, Wang YM,
Zhang MJ and Chen N: Role of moesin in renal fibrosis. PloS One.
9:e1129362014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eddy AA: Overview of the cellular and
molecular basis of kidney fibrosis. Kidney Int Suppl (2011). 4:2–8.
2014. View Article : Google Scholar
|
|
4
|
Strutz F, Zeisberg M, Renziehausen A,
Raschke B, Becker V, van Kooten C and Müller G: TGF-beta 1 induces
proliferation in human renal fibroblasts via induction of basic
fibroblast growth factor (FGF-2). Kidney Int. 59:579–592. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oujo B, Muñoz-Félix JM, Arévalo M,
Núñez-Gómez E, Pérez-Roque L, Pericacho M, González-Núñez M, Langa
C, Martínez-Salgado C, Perez-Barriocanal F, et al: L-endoglin
overexpression increases renal fibrosis after unilateral ureteral
obstruction. PloS One. 9:e1103652014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deshpande SD, Putta S, Wang M, Lai JY,
Bitzer M, Nelson RG, Lanting LL, Kato M and Natarajan R:
Transforming growth factor-β-induced cross talk between p53 and a
microRNA in the pathogenesis of diabetic nephropathy. Diabetes.
62:3151–3162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Overstreet JM, Samarakoon R, Meldrum KK
and Higgins PJ: Redox control of p53 in the transcriptional
regulation of TGF-β1 target genes through SMAD cooperativity. Cell
Signal. 26:1427–1436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Samarakoon R, Dobberfuhl AD, Cooley C,
Overstreet JM, Patel S, Goldschmeding R, Meldrum KK and Higgins PJ:
Induction of renal fibrotic genes by TGF-β1 requires EGFR
activation, p53 and reactive oxygen species. Cell Signal.
25:2198–2209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manickam N, Patel M, Griendling KK, Gorin
Y and Barnes JL: RhoA/Rho kinase mediates TGF-β1-induced kidney
myofibroblast activation through Poldip2/Nox4-derived reactive
oxygen species. Am J Physiol Renal Physiol. 307:F159–F171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim D, Lee AS, Jung YJ, Yang KH, Lee S,
Park SK, Kim W and Kang KP: Tamoxifen ameliorates renal
tubulointerstitial fibrosis by modulation of estrogen receptor
α-mediated transforming growth factor-β1/Smad signaling pathway.
Nephrol Dial Transplant. 29:2043–2053. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang L, Chi YF, Yuan ZT, Zhou WC, Yin PH,
Zhang XM, Peng W and Cai H: Astragaloside IV inhibits renal
tubulointerstitial fibrosis by blocking TGF-β/Smad signaling
pathway in vivo and in vitro. Exp Biol Med (Maywood).
239:1310–1324. 2014. View Article : Google Scholar
|
|
12
|
Park SH, Cho HJ, Jeong YJ, Shin JM, Kang
JH, Park KK, Choe JY, Park YY, Bae YS, Han SM, et al: Melittin
inhibits TGF-β-induced pro-fibrotic gene expression through the
suppression of the TGFβRII-Smad, ERK1/2 and JNK-mediated signaling
pathway. Am J Chin Med. 42:1139–1152. 2014. View Article : Google Scholar
|
|
13
|
Zhang L, Zhang J, Liu X, Liu S and Tian J:
Tribbles 3 regulates the fibrosis cytokine TGF-β 1 through
ERK1/2-MAPK signaling pathway in diabetic nephropathy. J Immunol
Res. 2014:2403962014. View Article : Google Scholar
|
|
14
|
Chen G, Chen X, Sukumar A, Gao B, Curley
J, Schnaper HW, Ingram AJ and Krepinsky JC: TGFβ receptor I
transactivation mediates stretch-induced Pak1 activation and CTGF
upregulation in mesangial cells. J Cell Sci. 126:3697–3712. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lanaya H, Natarajan A, Komposch K, Li L,
Amberg N, Chen L, Wculek SK, Hammer M, Zenz R, Peck-Radosavljevic
M, et al: EGFR has a tumour-promoting role in liver macrophages
during hepatocellular carcinoma formation. Nat Cell Biol.
16:972–981. 2014. View
Article : Google Scholar :
|
|
16
|
Salazar N, Muñoz D, Kallifatidis G, Singh
RK, Jordà M and Lokeshwar BL: The chemokine receptor CXCR7
interacts with EGFR to promote breast cancer cell proliferation.
Mol Cancer. 13:1982014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoo YH, Kim YR, Kim MS, Lee KJ, Park KH
and Hahn JH: YAC tripeptide of epidermal growth factor promotes the
proliferation of HaCaT keratinocytes through activation of EGFR.
BMB Rep. 47:581–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kundu S, Sengupta S and Bhattacharyya A:
NF-κB acts downstream of EGFR in regulating low dose cadmium
induced primary lung cell proliferation. Biometals. 26:897–911.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu N, Guo JK, Pang M, Tolbert E,
Ponnusamy M, Gong R, Bayliss G, Dworkin LD, Yan H and Zhuang S:
Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.
J Am Soc Nephrol. 23:854–867. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ponnusamy M, Zhou X, Yan Y, Tang J,
Tolbert E, Zhao TC, Gong R and Zhuang S: Blocking sirtuin 1 and 2
inhibits renal interstitial fibroblast activation and attenuates
renal interstitial fibrosis in obstructive nephropathy. J Pharmacol
Exp Ther. 350:243–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han SY, Ding HR, Zhao W, Teng F and Li PP:
Enhancement of gefitinib-induced growth inhibition by Marsdenia
tenacissima extract in non-small cell lung cancer cells expressing
wild or mutant EGFR. BMC Complement Altern Med. 14:1652014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakurai MA, Ozaki Y, Okuzaki D, Naito Y,
Sasakura T, Okamoto A, Tabara H, Inoue T, Hagiyama M, Ito A, et al:
Gefitinib and luteolin cause growth arrest of human prostate cancer
PC-3 cells via inhibition of cyclin G-associated kinase and
induction of miR-630. PloS One. 9:e1001242014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bersanelli M, Tiseo M, Artioli F, Lucchi L
and Ardizzoni A: Gefitinib and afatinib treatment in an advanced
non-small cell lung cancer (NSCLC) patient undergoing hemodialysis.
Anticancer Res. 34:3185–3188. 2014.PubMed/NCBI
|
|
24
|
Deangelo DJ, Neuberg D, Amrein PC,
Berchuck J, Wadleigh M, Sirulnik LA, Galinsky I, Golub T, Stegmaier
K and Stone RM: A phase II study of the EGFR inhibitor gefitinib in
patients with acute myeloid leukemia. Leuk Res. 38:430–434. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kalykaki A, Agelaki S, Kallergi G, Xyrafas
A, Mavroudis D and Georgoulias V: Elimination of EGFR-expressing
circulating tumor cells in patients with metastatic breast cancer
treated with gefitinib. Cancer Chemother Pharmacol. 73:685–693.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen SC, Guh JY, Lin TD, Chiou SJ, Hwang
CC, Ko YM and Chuang LY: Gefitinib attenuates transforming growth
factor-beta1-activated mitogen-activated protein kinases and
mitogenesis in NRK-49F cells. Transl Res. 158:214–224. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Midgley AC, Rogers M, Hallett MB, Clayton
A, Bowen T, Phillips AO and Steadman R: Transforming growth
factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast
differentiation is mediated by hyaluronan (HA)-facilitated
epidermal growth factor receptor (EGFR) and CD44 co-localization in
lipid rafts. J Biol Chem. 288:14824–14838. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao C, Chen J, Yu B, Wu X, Dai C, Zhou C
and Chen X: Effect of modified taohongsiwu decoction on patients
with chemotherapy-induced hand-foot syndrome. J Tradit Chin Med.
34:10–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yonesaka K, Suzumura T, Tsukuda H,
Hasegawa Y, Ozaki T, Sugiura T and Fukuoka M: Erlotinib is a
well-tolerated alternate treatment for non-small cell lung cancer
in cases of gefitinib-induced hepatotoxicity. Anticancer Res.
34:5211–5215. 2014.PubMed/NCBI
|
|
30
|
Madke B, Gole P, Kumar P and Khopkar U:
Dermatological side effects of epidermal growth factor receptor
inhibitors: 'PRIDE' complex. Indian J Dermatol. 59:271–274. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Funakoshi Y, Takeuchi Y and Maeda H:
Pneumonectomy after response to gefitinib treatment for lung
adenocarcinoma. Asian Cardiovasc Thorac Ann. 21:482–484. 2013.
View Article : Google Scholar
|
|
32
|
Kuwabara A, Nakade M, Tamai H,
Tsuboyama-Kasaoka N and Tanaka K: The association between vitamin E
intake and hypertension: Results from the re-analysis of the
national health and nutrition survey. J Nutr Sci Vitaminol (Tokyo).
60:239–245. 2014. View Article : Google Scholar
|
|
33
|
Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z
and Hasanzade J: Effect of alpha-lipoic acid and vitamin E
supplementation on oxidative stress, inflammation and malnutrition
in hemodialysis patients. Iran J Kidney Dis. 7:461–467.
2013.PubMed/NCBI
|
|
34
|
Hsieh CL, Chen KC, Lin PX, Peng CC and
Peng RY: Resveratrol and vitamin E rescue valproic acid-induced
teratogenicity: The mechanism of action. Clin Exp Pharmacol
Physiol. 41:210–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen X, Tang Q, Wu J, Feng Y, Huang J and
Cai W: Effect of vitamin E supplementation on oxidative stress in a
rat model of diet-induced obesity. Int J Vitam Nutr Res.
79:255–263. 2009. View Article : Google Scholar
|
|
36
|
Tasanarong A, Kongkham S, Thitiarchakul S
and Eiam-Ong S: Vitamin E ameliorates renal fibrosis in ureteral
obstruction: Role of maintaining BMP-7 during
epithelial-to-mesenchymal transition. J Med Assoc Thai. 94(Suppl
7): S10–S18. 2011.
|
|
37
|
Hamama S, Gilbert-Sirieix M, Vozenin MC
and Delanian S: Radiation-induced enteropathy: Molecular basis of
pentoxifylline-vitamin E anti-fibrotic effect involved TGF-β1
cascade inhibition. Radiother Oncol. 105:305–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang QL, Yuan JL, Tao YY, Zhang Y, Liu P
and Liu CH: Fuzheng Huayu recipe and vitamin E reverse renal
interstitial fibrosis through counteracting TGF-beta1-induced
epithelial-to-mesenchymal transition. J Ethnopharmacol.
127:631–640. 2010. View Article : Google Scholar
|
|
39
|
Knebel B, Lehr S, Hartwig S, Haas J, Kaber
G, Dicken HD, Susanto F, Bohne L, Jacob S, Nitzgen U, et al:
Phosphorylation of sterol regulatory element-binding protein
(SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism
and the secretome of human liver cell line HepG2. Arch Physiol
Biochem. 120:216–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He W, Wang Z, Luo Z, Yu Q, Jiang Y, Zhang
Y, Zhou Z, Smith AJ and Cooper PR: LPS promote the odontoblastic
differentiation of human dental pulp stem cells via MAPK signaling
pathway. J Cell Physiol. 230:554–561. 2015. View Article : Google Scholar
|
|
41
|
Wang D, Warner GM, Yin P, Knudsen BE,
Cheng J, Butters KA, Lien KR, Gray CE, Garovic VD, Lerman LO, et
al: Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in
a murine renal artery stenosis model. Am J Physiol Renal Physiol.
304:F938–F947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiao HB, Liu RH, Ling GH, Xiao L, Xia YC,
Liu FY, Li J, Liu YH, Chen QK, Lv JL, et al: HSP47 regulates ECM
accumulation in renal proximal tubular cells induced by TGF-beta1
through ERK1/2 and JNK MAPK pathways. Am J Physiol Renal Physiol.
303:F757–F765. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yiang GT, Chou PL, Hung YT, Chen JN, Chang
WJ, Yu YL and Wei CW: Vitamin C enhances anticancer activity in
methotrexatetreated Hep3B hepatocellular carcinoma cells. Oncol
Rep. 32:1057–1063. 2014.PubMed/NCBI
|
|
44
|
Yu YL, Yiang GT, Chou PL, Tseng HH, Wu TK,
Hung YT, Lin PS, Lin SY, Liu HC, Chang WJ and Wei CW: Dual role of
acetaminophen in promoting hepatoma cell apoptosis and kidney
fibroblast proliferation. Mol Med Rep. 9:2077–2084. 2014.PubMed/NCBI
|
|
45
|
Nho KJ, Chun JM and Kim HK: Agrimonia
pilosa ethanol extract induces apoptotic cell death in HepG2 cells.
J Ethnopharmacol. 138:358–363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu YL, Yu SL, Su KJ, Wei CW, Jian MH, Lin
PC, Tseng IH, Lin CC, Su CC, Chan DC, et al: Extended
O6-methylguanine methyltransferase promoter hypermethylation
following n-butylidenephthalide combined with 1,3-bis
(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human
hepatocellular carcinoma cell growth. J Agric Food Chem.
58:1630–1638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wei CW, Lin CC, Yu YL, Lin CY, Lin PC, Wu
MT, Chen CJ, Chang W, Lin SZ, Chen YL and Harn HJ:
n-Butylidenephthalide induced apoptosis in the A549 human lung
adenocarcinoma cell line by coupled down-regulation of AP-2alpha
and telomerase activity. Acta Pharmacol Sin. 30:1297–1306. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu YL, Su KJ, Chen CJ, Wei CW, Lin CJ,
Yiang GT, Lin SZ, Harn HJ and Chen YL: Synergistic anti-tumor
activity of isochaihulactone and paclitaxel on human lung cancer
cells. J Cell Physiol. 227:213–222. 2012. View Article : Google Scholar
|
|
49
|
Guo Y, Li Z, Ding R, Li H, Zhang L, Yuan W
and Wang Y: Parathyroid hormone induces epithelial-to-mesenchymal
transition via the Wnt/β-catenin signaling pathway in human renal
proximal tubular cells. Int J Clin Exp Pathol. 7:5978–5987.
2014.
|
|
50
|
Wei J, Li Z and Yuan F: Evodiamine might
inhibit TGF-beta1-induced epithelial-mesenchymal transition in
NRK52E cells via Smad and PPAR-gamma pathway. Cell Biol Int.
38:875–880. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun YB, Qu X, Li X, Nikolic-Paterson DJ
and Li J: Endothelial dysfunction exacerbates renal interstitial
fibrosis through enhancing fibroblast Smad3 linker phosphorylation
in the mouse obstructed kidney. PloS One. 8:e840632013. View Article : Google Scholar
|
|
52
|
Qu X, Zhang X, Yao J, Song J,
Nikolic-Paterson DJ and Li J: Resolvins E1 and D1 inhibit
interstitial fibrosis in the obstructed kidney via inhibition of
local fibroblast proliferation. J Pathol. 228:506–519. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dutton SJ, Ferry DR, Blazeby JM, Abbas H,
Dahle-Smith A, Mansoor W, Thompson J, Harrison M, Chatterjee A,
Falk S, et al: Gefitinib for oesophageal cancer progressing after
chemotherapy (COG): A phase 3, multicentre, double-blind,
placebo-controlled randomised trial. Lancet Oncol. 15:894–904.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liao XH, Zhang L, Chen GT, Yan RY, Sun H,
Guo H and Liu Q: Augmenter of liver regeneration inhibits
TGF-β1-induced renal tubular epithelial-to-mesenchymal transition
via suppressing TβR II expression in vitro. Exp Cell Res.
327:287–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lan A, Qi Y and Du J: Akt2 mediates
TGF-β1-induced epithelial to mesenchymal transition by deactivating
GSK3β/snail signaling pathway in renal tubular epithelial cells.
Cell Physiol Biochem. 34:368–382. 2014. View Article : Google Scholar
|
|
56
|
Qi R, Li W and Yu S: FK506 inhibits the
mice glomerular mesangial cells proliferation by affecting the
transforming growth factor-β and Smads signal pathways. Renal Fail.
36:589–592. 2014. View Article : Google Scholar
|
|
57
|
Guo W, Xu H, Chen J, Yang Y, Jin JW, Fu R,
Liu HM, Zha XL, Zhang ZG and Huang WY: Prohibitin suppresses renal
interstitial fibroblasts proliferation and phenotypic change
induced by transforming growth factor-beta1. Mol Cell Biochem.
295:167–177. 2007. View Article : Google Scholar
|
|
58
|
Zhu B, Jin Y, Han L, Chen H, Zhong F, Wang
W and Chen N: Proteasome inhibitor inhibits proliferation and
induces apoptosis in renal interstitial fibroblasts. Pharmacol Rep.
65:1357–1365. 2013. View Article : Google Scholar
|
|
59
|
Rodríguez-Barbero A, Dorado F, Velasco S,
Pandiella A, Banas B and Lopez-Novoa JM: TGF-beta1 induces COX-2
expression and PGE2 synthesis through MAPK and PI3K pathways in
human mesangial cells. Kidney Int. 70:901–909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Loeffler I, Hopfer U, Koczan D and Wolf G:
Type VIII collagen modulates TGF-β1-induced proliferation of
mesangial cells. J Am Soc Nephrol. 22:649–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
